Sr. Director, Translational & Clinical Pharmacology
Inhibrx, Inc
Clinical pharmacologist supporting the development of drug candidates by characterizing their exposure profile and resultant downstream pharamacodynamic effects. Experience in informing first-in-human dose selection through recommended Phase 2 dosing and regulatory submissions. Specializing in analyzing pharmacokinetic data through non-compartmental analysis as well as pharmacometric tools for population PK modeling, covariate analyses, simulations, exposure/response relationship characterization and more.
